July 21st, 2020

NEUREVO wins Munich Business Plan Competition Phase 3!

May 12th, 2020

NEUREVO is under the top 10 of over 100 participants in the Munich Business Plan Competition Phase 2.

March 16th, 2020

NEUREVO was selected as one of the best participants of Phase 2 (Konzeptphase) of Science4Life Venture Cup and participated in the “Academy Days”.

March 3rd , 2020

NEUREVO reached the top 10 of 150 participants of phase 1 of the Munich business plan competition.

November 22th, 2019

NEUREVO was selected as one of the best participants of Phase 1 (Ideenphase) of Science4Life Venture Cup and participated in the “Academy Days” in Frankfurt

July 12th, 2019

NEUREVO (former project name “GLYMIPRO”) took part in the three-month “EIT Health BioEntrepreneurship Lab Oxford-Munich 2019” and validated their innovative biotech business concept:

July 11th, 2019

NEUREVO (former project name “GLYMIPRO”) presented their top-class research to 19 investors, four pharmaceutical companies, one family office and one industry partner on the “5th Munich Life Science Pitch Day” of the High-Tech Gründerfond (HTGF).